- Novo Nordisk Inc. (Minneapolis, MN)
- … sales aids used, and any other information that will be useful for future sales calls Efficiently manage time and prioritize tasks and available resources to ... About the Department The Strategy & Rare Disease (STARS) organization...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations ... model in US beyond a 5-year time horizon. This department serves as the insiders of the US market...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
- Eisai, Inc (Los Angeles, CA)
- …and retain and develop top talentDemonstrated ability to read and apply differential sales reports to maximize sales opportunities within AreaDemonstrated ... assigned health systems for Eisai's oncology portfolio and manage a team of sales professionals. The ABL is responsible for the relationships with Eisai's Oncology… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- About the Department The Finance, Insights & Enterprise Solutions department brings insights and intelligence to inform decision making & drives digitalization ... growth and operational excellence across the value chain while innovating for future capabilities. Our focus on innovation ensures we're constantly building … more
- Novo Nordisk Inc. (Los Angeles, CA)
- About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations ... model in US beyond a 5-year time horizon. This department serves as the insiders of the US market...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations ... model in US beyond a 5-year time horizon. This department serves as the insiders of the US market...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
- Novo Nordisk Inc. (Los Angeles, CA)
- About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations ... model in US beyond a 5-year time horizon. This department serves as the insiders of the US market...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Graduates will interact across the commercial ecosystem (Marketing, Commercial Operations, Finance, Sales Execution). The graduate will have opportunity to work ... on this mission and take Novo Nordisk into the future . **4 positions available** The Position The US Business...of the commercial ecosystem (Marketing, Commercial Operations, Finance, and Sales ). Graduates will be included in and drive national… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- About the Department The Finance, Insights, and Enterprise Solutions dept. (FIES) brings insights and intelligence to inform decision making & drives digitalization ... growth and operational excellence across the value chain while innovating for future capabilities. Our focus on innovation ensures we're constantly building … more
- Novo Nordisk Inc. (Plainsboro, NJ)
- About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations ... model in US beyond a 5-year time horizon. This department serves as the insiders of the US market...market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes… more
